NG Industries Ltd
- Market cap
- ₹ 34 Cr.
- P/E
- 17.3x
- P/B
- 1.04x
- 52-week range
- 99 – 160
- ROE
- 5%
- ROCE
- 5.9%
- Dividend yield
- 3.5%
- Debt / equity
- 0.05
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- BSE
About
N G Industries Ltd is engaged in healthcare services. The Company's healthcare services include clinics, diagnostics, inpatient, and outpatient services, as well as pharmacy dispensing. Its divisions include N G Medicare and Calcutta Hope Infertility Clinic, N G Nursing Home, and N G Pharmacy. It provides various patient services delivered through clinical establishment for indoor patient services, as well as outpatient services, including diagnostic services and clinics with pharmacy, pathology and radiology services, and others. The N G Medicare & Calcutta Hope Infertility Clinic is a diagnostic center with daycare and nursing home facilities providing a range of medical services in the fields of pathology, radiology, cardiology, gastroenterology, infertility, minimal invasive surgery, and multispecialty clinic. Its N G Nursing Home provides a 53-bedded indoor establishment in South Kolkata and its services to surgeries, including general surgery, joint replacement, and urology.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →NG Industries Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)17.3 against a typical 21: cheaper than most peers (1st = cheapest).13th of 34
- Sales growth+13.8% against a typical +19.1% from a year earlier.21st of 31
- Profit growth+105.3% against a typical +25.2% from a year earlier.3rd of 24
- Share price, 3 months−14.7% against a typical −7.7%.25th of 33
- Size₹ 33.7 Cr. market value against a typical ₹ 83 Cr. (1st = largest).19th of 34
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Expenses | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 4 |
| Operating Profit | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| OPM % | 12% | 10.1% | 12.5% | 10.5% | 10.3% | 10.3% | 12.3% | 8.9% | 7.9% | 11.4% | 14.5% | 10.2% |
| Other Income | 0 | 0 | 2 | 0 | 3 | 8 | −3 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 0 | 2 | 1 | 3 | 8 | −3 | 0 | 1 | 1 | 1 | 1 |
| Tax % | 7.3% | 10.4% | 13.8% | 14% | 15.2% | 15.2% | −13.8% | 25.9% | 27.1% | 28.8% | 0% | 21.6% |
| Net Profit | 1 | 0 | 2 | 1 | 3 | 7 | −2 | 0 | 0 | 0 | 1 | 0 |
| EPS in Rs | 1.91 | 1.28 | 5.79 | 1.49 | 8.86 | 20.03 | −7.25 | 0.57 | 1.28 | 1.25 | 2.06 | 1.16 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 0%
- 5 Years
- 7%
- 3 Years
- −4%
- TTM
- 2%
- 10 Years
- 0%
- 5 Years
- 22%
- 3 Years
- 7%
- TTM
- −74%
- 10 Years
- 4%
- 5 Years
- 20%
- 3 Years
- 0%
- TTM
- —
- 10 Years
- 6%
- 5 Years
- 3%
- 3 Years
- 2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| NG Industries Ltd | ₹ 99.00 | ₹ 34 Cr. | 17.3x | 1x | 5% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Rajesh Goenka
- Chairman of the Board, Whole Time Director
- Santosh Kumar Thakur
- Chief Financial Officer
- Bratati Bhattacharya
- Company Secretary and Compliance Officer
Prices are delayed and for information only. Nothing on this page is investment advice.